XML 19 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Class A and Class B common stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Beginning balance at Dec. 31, 2021 $ 2,175,957 $ 175 $ 7,874,038 $ (47,739) $ (5,650,517)
Issuance of common stock upon exercise of stock options   1 8,182    
Equity-based compensation     55,593    
Foreign currency translation adjustments, net of tax 3,011     3,011  
Actuarial gain on defined severance benefits, net of tax 3,811     3,811  
Net income (loss) (209,294)       (209,294)
Ending balance at Mar. 31, 2022 2,037,261 $ 176 7,937,813 (40,917) (5,859,811)
Beginning balance (in shares) at Dec. 31, 2021   1,754,203      
Issuance of common units, equity-based compensation plan (in shares)   4,147      
Issuance of common stock upon settlement of restricted stock units (in shares)   2,708      
Ending balance (in shares) at Mar. 31, 2022   1,761,058      
Beginning balance at Dec. 31, 2022 2,413,913 $ 177 8,154,076 2,219 (5,742,559)
Issuance of common stock upon exercise of stock options     3,494    
Issuance of common stock upon settlement of restricted stock units   1      
Equity-based compensation     69,899    
Foreign currency translation adjustments, net of tax (18,988)     (18,988)  
Actuarial gain on defined severance benefits, net of tax 856     856  
Net income (loss) 90,855       90,855
Ending balance at Mar. 31, 2023 $ 2,560,030 $ 178 $ 8,227,469 $ (15,913) $ (5,651,704)
Beginning balance (in shares) at Dec. 31, 2022   1,772,607      
Issuance of common units, equity-based compensation plan (in shares)   1,588      
Issuance of common stock upon settlement of restricted stock units (in shares)   3,096      
Ending balance (in shares) at Mar. 31, 2023   1,777,291